Tandem Diabetes Care, Inc. Fair Value Adjustment of Warrants
Tandem Diabetes Care, Inc. (TNDM) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2025-02-26
- Tandem Diabetes Care, Inc. fair value adjustment of warrants for the quarter ending 2022-12-31 was -$250.00K, a 881.25% decline year-over-year.
- Tandem Diabetes Care, Inc. fair value adjustment of warrants for the quarter ending 2022-09-30 was $12.00K, a 96.94% decline year-over-year.
- Tandem Diabetes Care, Inc. fair value adjustment of warrants for the quarter ending 2022-06-30 was $57.00K, a 79.04% decline year-over-year.
- Tandem Diabetes Care, Inc. fair value adjustment of warrants for the quarter ending 2022-03-31 was -$34.00K, a 104.93% decline year-over-year.
- Tandem Diabetes Care, Inc. fair value adjustment of warrants for fiscal 2024 was $0.00.
- Tandem Diabetes Care, Inc. fair value adjustment of warrants for fiscal 2023 was $0.00.
- Tandem Diabetes Care, Inc. fair value adjustment of warrants for fiscal 2022 was -$147.00K, a 110.61% decline from fiscal 2021.
- Tandem Diabetes Care, Inc. fair value adjustment of warrants for fiscal 2021 was $1.39M, a 91.89% decline from fiscal 2020.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 6 month as first filed | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-26 | ||||||
| 2023-12-31 | $0.00 10-K · filed 2025-02-26 | ||||||
| 2022-12-31 | -$250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$238.00K derived: sum of 2 quarters · filed 2025-02-26 | -$181.00K derived: sum of 3 quarters · filed 2025-02-26 | -$147.00K 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $12.00K 10-Q · filed 2023-11-01 | -$12.00K 10-Q · filed 2022-11-02 | $69.00K derived: sum of 2 quarters · filed 2023-11-01 | $103.00K 10-Q · filed 2023-11-01 | -$103.00K 10-Q · filed 2022-11-02 | $67.00K derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-06-30 | $57.00K 10-Q · filed 2023-08-03 | -$57.00K 10-Q · filed 2022-08-03 | $91.00K 10-Q · filed 2023-08-03 | -$91.00K 10-Q · filed 2022-08-03 | $55.00K derived: sum of 3 quarters · filed 2024-02-21 | $447.00K derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-03-31 | -$34.00K 10-Q · filed 2022-05-04 | -$2.00K derived: sum of 2 quarters · filed 2024-02-21 | $390.00K derived: sum of 3 quarters · filed 2024-02-21 | $662.00K derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $424.00K derived: sum of 2 quarters · filed 2024-02-21 | $696.00K derived: sum of 3 quarters · filed 2024-02-21 | $1.39M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $392.00K 10-Q · filed 2022-11-02 | $664.00K derived: sum of 2 quarters · filed 2022-11-02 | $1.35M 10-Q · filed 2022-11-02 | -$1.47M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | $272.00K 10-Q · filed 2022-08-03 | $962.00K 10-Q · filed 2022-08-03 | -$1.86M derived: sum of 3 quarters · filed 2023-02-22 | $1.79M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | $690.00K 10-Q · filed 2022-05-04 | -$2.13M derived: sum of 2 quarters · filed 2023-02-22 | $1.52M derived: sum of 3 quarters · filed 2023-02-22 | $15.86M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | -$2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $829.00K derived: sum of 2 quarters · filed 2023-02-22 | $15.16M derived: sum of 3 quarters · filed 2023-02-22 | $17.09M 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $3.65M 10-Q · filed 2021-11-03 | $17.98M derived: sum of 2 quarters · filed 2021-11-03 | $19.91M 10-Q · filed 2021-11-03 | $20.13M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | $14.34M 10-Q · filed 2021-08-04 | $16.26M 10-Q · filed 2021-08-04 | $16.48M derived: sum of 3 quarters · filed 2022-02-22 | $14.16M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-03-31 | $1.92M 10-Q · filed 2021-05-05 | $2.15M derived: sum of 2 quarters · filed 2022-02-22 | -$173.00K derived: sum of 3 quarters · filed 2022-02-22 | $251.00K derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | $226.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$2.10M derived: sum of 2 quarters · filed 2022-02-22 | -$1.67M derived: sum of 3 quarters · filed 2022-02-22 | $11.07M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | -$2.32M 10-Q · filed 2020-11-05 | -$1.90M derived: sum of 2 quarters · filed 2020-11-05 | $10.85M 10-Q · filed 2020-11-05 | $8.30M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | $424.00K 10-Q · filed 2020-07-30 | $13.17M 10-Q · filed 2020-07-30 | $10.62M derived: sum of 3 quarters · filed 2021-02-24 | $22.89M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | $12.75M 10-Q · filed 2020-04-30 | $10.20M derived: sum of 2 quarters · filed 2021-02-24 | $22.46M derived: sum of 3 quarters · filed 2021-02-24 | $65.01M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | -$2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $9.72M derived: sum of 2 quarters · filed 2021-02-24 | $52.27M derived: sum of 3 quarters · filed 2021-02-24 | $66.49M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $12.27M 10-Q · filed 2019-11-04 | $54.81M derived: sum of 2 quarters · filed 2019-11-04 | $69.04M 10-Q · filed 2019-11-04 | ||||
| 2018-06-30 | $42.55M 10-Q · filed 2019-08-01 | $56.78M 10-Q · filed 2019-08-01 | |||||
| 2018-03-31 | $14.23M 10-Q · filed 2019-04-30 | ||||||
| 2017-12-31 | -$1.02M 10-K · filed 2020-02-24 | ||||||
| 2014-12-31 | $0.00 10-K · filed 2015-02-24 | ||||||
| 2013-12-31 | $5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $5.72M derived: sum of 2 quarters · filed 2016-02-24 | $6.17M derived: sum of 3 quarters · filed 2016-02-24 | $9.00M 10-K · filed 2016-02-24 | |||
| 2013-09-30 | -$272.03K 10-Q · filed 2014-11-06 | $181.19K derived: sum of 2 quarters · filed 2014-11-06 | $3.01M 10-Q · filed 2014-11-06 | ||||
| 2013-06-30 | $453.22K 10-Q · filed 2014-07-31 | $3.28M 10-Q · filed 2014-07-31 | |||||
| 2013-03-31 | $2.83M 10-Q · filed 2014-05-06 | ||||||
| 2012-12-31 | -$2.56M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |